TY - JOUR
T1 - Seasonality Patterns in Bipolar Disorder
T2 - Associations With Clinical Phenotypes and Treatment-Related Outcomes
AU - Bostan, Siralp
AU - Melhuish Beaupre, Lindsay M.
AU - Ercis, Mete
AU - Coombes, Brandon J.
AU - Romo-Nava, Francisco
AU - Prieto, Miguel L.
AU - Cuellar Barboza, Alfredo B.
AU - McElroy, Susan L.
AU - Frye, Mark A.
AU - Biernacka, Joanna M.
AU - Ozerdem, Aysegul
N1 - Publisher Copyright:
© 2025 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2025
Y1 - 2025
N2 - Background: Mood episodes in bipolar disorder (BD) follow a seasonal pattern in approximately 25% of patients. We aimed to examine the associations of specific seasonality patterns in BD with various clinical phenotypes and treatment-related outcomes. Methods: Patients from the Mayo Clinic Bipolar Disorder Biobank with available seasonality data were included in the study. Among those reporting any seasonality, participants were further categorized into four seasonality groups: fall/winter depression, spring/summer (hypo)mania, biphasic (fall/winter depression with spring/summer (hypo)mania), and equinoctial seasonality (any mood episode occurring in spring or fall). Regression models were used, treating seasonality patterns as the predictor of clinical phenotypes (BD subtype, early onset, history of psychosis, suicide attempt, rapid cycling), lifetime medication exposure (number of unique antidepressants, antipsychotics, and any psychotropics) and treatment response to mood stabilizers (Alda A score). Results: Among 1702 patients with BD (61.5% female, mean age = 41.43 ± 14.73 years), 44.6% reported seasonal mood episodes. Individuals with any seasonality were more likely to have BD-I (OR = 1.29, p = 0.024), early onset (OR = 1.29, p = 0.026), exposure to higher lifetime number of antipsychotics (IRR = 1.20, p < 0.001) and any psychotropics (IRR = 1.13, p < 0.001). Fall/winter depression was associated with a higher lifetime number of antidepressants (IRR = 1.18, p = 0.021), any psychotropics (IRR = 1.14, p = 0.013), worse response to lithium (β = −0.82, p = 0.029) and all mood stabilizers (β = −0.69, p = 0.014). Spring/summer (hypo)mania showed negative associations with rapid cycling (OR = 0.36, p < 0.001) and lifetime number of antidepressants (IRR = 0.70, p = 0.013). Equinoctial seasonality was linked to a history of psychosis (OR = 1.76, p = 0.004). Conclusion: Seasonality in BD is associated with distinct clinical features and treatment-related outcomes. Specific seasonality patterns, particularly fall/winter depression, may reflect a more complex and difficult-to-treat illness course. These findings highlight the need for research to better characterize seasonality subtypes beyond a binary “seasonal” vs. “non-seasonal” classification and to explore how these patterns influence the illness course and management of BD.
AB - Background: Mood episodes in bipolar disorder (BD) follow a seasonal pattern in approximately 25% of patients. We aimed to examine the associations of specific seasonality patterns in BD with various clinical phenotypes and treatment-related outcomes. Methods: Patients from the Mayo Clinic Bipolar Disorder Biobank with available seasonality data were included in the study. Among those reporting any seasonality, participants were further categorized into four seasonality groups: fall/winter depression, spring/summer (hypo)mania, biphasic (fall/winter depression with spring/summer (hypo)mania), and equinoctial seasonality (any mood episode occurring in spring or fall). Regression models were used, treating seasonality patterns as the predictor of clinical phenotypes (BD subtype, early onset, history of psychosis, suicide attempt, rapid cycling), lifetime medication exposure (number of unique antidepressants, antipsychotics, and any psychotropics) and treatment response to mood stabilizers (Alda A score). Results: Among 1702 patients with BD (61.5% female, mean age = 41.43 ± 14.73 years), 44.6% reported seasonal mood episodes. Individuals with any seasonality were more likely to have BD-I (OR = 1.29, p = 0.024), early onset (OR = 1.29, p = 0.026), exposure to higher lifetime number of antipsychotics (IRR = 1.20, p < 0.001) and any psychotropics (IRR = 1.13, p < 0.001). Fall/winter depression was associated with a higher lifetime number of antidepressants (IRR = 1.18, p = 0.021), any psychotropics (IRR = 1.14, p = 0.013), worse response to lithium (β = −0.82, p = 0.029) and all mood stabilizers (β = −0.69, p = 0.014). Spring/summer (hypo)mania showed negative associations with rapid cycling (OR = 0.36, p < 0.001) and lifetime number of antidepressants (IRR = 0.70, p = 0.013). Equinoctial seasonality was linked to a history of psychosis (OR = 1.76, p = 0.004). Conclusion: Seasonality in BD is associated with distinct clinical features and treatment-related outcomes. Specific seasonality patterns, particularly fall/winter depression, may reflect a more complex and difficult-to-treat illness course. These findings highlight the need for research to better characterize seasonality subtypes beyond a binary “seasonal” vs. “non-seasonal” classification and to explore how these patterns influence the illness course and management of BD.
KW - bipolar disorder
KW - lithium
KW - mood stabilizers
KW - seasonal depression
KW - seasonal mania
KW - seasonality
KW - treatment response
UR - https://www.scopus.com/pages/publications/105026065931
U2 - 10.1111/acps.70063
DO - 10.1111/acps.70063
M3 - Article
C2 - 41450248
AN - SCOPUS:105026065931
SN - 0001-690X
JO - Acta Psychiatrica Scandinavica
JF - Acta Psychiatrica Scandinavica
ER -